Table 2. Regression analysis for factors associated with PE in ED patients with COVID-19.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
Variables | OR | 95% CI | P-value | OR | 95% CI | P-value |
Age per 5 years | 1.08 | 0.96–1.21 | 0.20 | |||
Male sex | 1.01 | 0.54–1.88 | 0.97 | |||
BMI (kg/m 2 ) | ||||||
<25 | Reference | |||||
25–30 | 1.06 | 0.51–2.18 | 0.88 | |||
≥30 | 0.69 | 0.30–1.59 | 0.38 | |||
Chronic comorbidity | ||||||
COPD | 0.84 | 0.35–2.05 | 0.71 | |||
Malignant neoplasms | 2.29 | 0.84–6.28 | 0.11 | 2.54 | 0.83–7.73 | 0.10 |
CCI ≥4 | 1.55 | 0.84–2.84 | 0.16 | |||
Vital signs | ||||||
Heart rate >100 bpm | 1.73 | 0.94–3.19 | 0.08 | 1.37 | 0.67–2.78 | 0.39 |
Temperature ≥38.5°C | 0.56 | 0.27–1.16 | 0.12 | |||
Laboratory results | ||||||
D-dimer per 1000 μg/L | 1.10 | 1.07–1.13 | <0.001 | 1.09 | 1.06–1.13 | <0.001 |
CRP >100 mg/L | 2.61 | 1.42–4.81 | 0.002 | 2.78 | 1.37–5.66 | 0.005 |
Ferritin >900 μg/L | 1.66 | 0.91–3.02 | 0.10 | |||
Lactate >1.8 mmol/L | 2.44 | 1.30–4.57 | 0.006 | 1.77 | 0.89–3.54 | 0.11 |
BMI, body mass index; bpm, beats per minute; CCI, Charlson Comorbidity Index; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; OR, Odds ratio.
Other variables listed in Table 1 but not shown here were not associated with PE in univariate analysis.